Leave Your Message
Explore our leading selection of premium biological and nutritional active ingredients designed for modern veterinary medicine.
Partnering globally to deliver state-of-the-art biological and chemical solutions.
Jiangxi Serum Pharma Industries Co., Ltd. stands as a premier supplier of high-grade pharmaceutical and nutritional ingredients based in China. For nearly a decade, our focus has remained on exporting biological products, vaccines, Western medicines, critical raw materials, intermediates, medical consumables, food additives, and premium plant extracts. By bridging the gap between state-of-the-art bio-fermentation laboratories and global animal health manufacturers, we ensure that premium pharmaceutical formulations achieve unmatched stability, safety, and therapeutic performance.
In the veterinary sector, the distinction between standard and premium formulations relies heavily on the quality of the Active Pharmaceutical Ingredients (APIs) and excipients. We work closely with research institutes and manufacturers globally to deliver ingredients that meet international standards (GMP, USP, EP). Our robust logistics network and rigorous quality control protocols ensure that each batch meets stringent veterinary pharmacopoeia specifications.
Analyzing market trends, technological shifts, and the high demand for premium APIs.
The global animal health market has transitioned from simple disease control to advanced preventative management and targeted therapy. Today, the demand for Animal Health Products For Premium Pharmaceutical Formulations is driven by livestock productivity goals, companion animal humanization, and strict regulatory standards regarding residue limits. Producers and veterinarians demand products that guarantee high bioavailability, minimal environmental impact, and zero risk of cross-contamination.
Chemical synthesis is no longer the sole pillar of veterinary medicine. Bio-fermentation has introduced highly pure probiotics, enzymatic proteins, and organic compounds that boost natural immunity. Microorganisms like Lactobacillus helveticus and Bifidobacterium are systematically integrated into feed additives and therapeutic formulations to stabilize animal gut microbiomes, thereby reducing the dependency on prophylactic antibiotics.
Global regulatory bodies, including the FDA and EFSA, are enforcing strict limits on the use of sub-therapeutic antibiotics as growth promoters. Consequently, premium formulations are adopting natural antimicrobials, organic acids, and probiotic strains to maintain animal growth indexes while ensuring food safety for human consumers.
Many veterinary medicines suffer from low solubility, poor stability, and low palatability. Delivering therapeutic doses to livestock via drinking water or feed requires specialized technology. This is where premium formulations come in, utilizing co-crystallization and tailored pre-mix designs to protect active molecules from degradation in acidic digestive environments, ensuring targeted release in the intestinal tract.
Providing biological products, vaccines, western medicines, raw materials, and intermediates.
Our pharmaceutical product line represents the pinnacle of veterinary medicine. We ensure that our biological products, vaccines, and western medicines are formulated using pure raw materials. Whether dealing with systemic bacterial infections in swine herds or chronic thromboembolic disorders in companion animals, our APIs provide the precise molecular structure needed for optimal therapeutic outcomes.
By offering critical veterinary compounds like Tilmicosin, Doramectin, and Ivermectin, we support the global supply chain in manufacturing finished dosage forms (injections, oral solutions, and premixes) that exhibit exceptional stability and consistent therapeutic serum levels in animals.
Deriving purity from nature to maintain body health and natural physiological balance.
Modern animal nutrition focuses on preventative health. Our range of nutritional ingredients spans plant-derived extracts, essential plant oils, proteins, and highly concentrated probiotics. These ingredients are designed to support animal immune systems, improve reproduction rates, and enhance feed conversion efficiency.
Natural extracts such as Shatavari (traditionally used for reproductive health and hormonal balance) and high-purity L-Ergothioneine serve as powerful antioxidants. They neutralize free radicals, reduce cellular oxidative stress in livestock during peak summer temperatures, and preserve meat and milk quality by protecting cellular integrity from the inside out.
Leveraging state-of-the-art technologies to customize pre-mixes, co-crystallizations, and bio-fermentations.
Homogeneous blending of micro-ingredients and APIs with high-quality carriers to ensure uniform drug distribution in feed, preventing segregation during transit.
Read More
Modifying the crystal lattice of veterinary APIs to dramatically improve solubility, dissolution rates, stability, and taste-masking properties.
Read More
Utilizing engineered microbial strains to produce active biomolecules, organic acids, and enzymes with high yield, purity, and environmental sustainability.
Read MoreHow premium formulations resolve complex clinical challenges in livestock and companion animals.
Respiratory diseases, particularly those caused by *Mycoplasma hyopneumoniae* and *Pasteurella multocida*, can cause severe economic losses in animal husbandry. Formulating a reliable, stable therapeutic agent like Tilmicosin Premix (20%) ensures that the drug remains stable in feed and is absorbed efficiently, achieving therapeutic concentrations in lung tissues rapidly to resolve infections without compromising feed intake.
Parasitic infections compromise animal health and feed conversion rates. Standard antiparasitic treatments often require frequent dosing, which increases labor costs and animal stress. By formulating premium, long-acting injections using high-grade Doramectin or Ivermectin APIs, manufacturers can achieve sustained release profiles. This protects cattle, sheep, and swine from internal and external parasites for weeks with a single injection.
In commercial livestock production, reproductive efficiency determines profitability. Premium veterinary formulations containing Oxytocin Injection are critical for managing labor, preventing postpartum uterine infections, and facilitating milk letdown. The purity of the API is paramount; impurities can lead to adverse systemic reactions or unpredictable uterine contractions, making high-purity biological sourcing essential.
As veterinary clinical care advances, companion animals (dogs and cats) are receiving treatments similar to human medicine. Enoxaparin Sodium API is highly sought after for premium veterinary formulations targeting feline arterial thromboembolism (FATE) and canine hypercoagulability. Sourcing low-molecular-weight heparin with consistent biological activity is critical for maintaining safe therapeutic margins in small animals.
Stay updated with our latest research, market analyses, and pharmaceutical breakthroughs.
An in-depth review of the growing demand for plant-based squalene as an adjuvant in animal vaccines and premium dermatological formulations, highlighting the industrial shift away from shark-derived alternatives.
Learn More
Detailing the therapeutic applications of this potent corticosteroid in treating acute inflammatory conditions, anaphylaxis, and respiratory distress across livestock and companion animal veterinary protocols.
Learn More
Reviewing the rapid approval process of Lilly's new small-molecule oral GLP1 receptor agonist, highlighting its flexible administration without water or fasting restrictions, and its potential implications for metabolic health research.
Learn MoreExplore our full range of high-quality active ingredients, probiotics, and therapeutic injections.
Jiangxi Serum Pharma Industries Co., Ltd. is a dedicated exporter of biological products, vaccines, western medicines, intermediates, and high-purity plant extracts, supporting the global pharmaceutical and animal health industries since 2017.
